Temenos AG
Temenos AG (TMSNY) Financial Performance & Income Statement Overview
Analyze Temenos AG (TMSNY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Temenos AG (TMSNY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Temenos AG TMSNY financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $232.20M | $318.92M | $246.92M | $248.38M |
| Cost of Revenue | $97.72M | $114.61M | $103.37M | $43.92M |
| Gross Profit | $134.47M | $204.32M | $143.55M | $204.47M |
| Gross Profit Ratio | $0.58 | $0.64 | $0.58 | $0.82 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $94.39M | $118.20M | $97.40M | $57.28M |
| Operating Expenses | $94.39M | $118.20M | $97.40M | $151.89M |
| Total Costs & Expenses | $192.11M | $232.81M | $200.77M | $195.81M |
| Interest Income | -$136000.00 | -$216000.00 | $0.00 | $4.09M |
| Interest Expense | $1.61M | $2.51M | $5.09M | $6.96M |
| Depreciation & Amortization | $29.26M | $32.44M | $33.33M | $32.81M |
| EBITDA | $68.38M | $114.63M | $79.59M | $84.78M |
| EBITDA Ratio | $0.29 | $0.36 | $0.32 | $0.34 |
| Operating Income | $40.09M | $86.12M | $46.15M | $52.58M |
| Operating Income Ratio | $0.17 | $0.27 | $0.19 | $0.21 |
| Other Income/Expenses (Net) | -$2.58M | -$6.44M | -$4.98M | -$4.89M |
| Income Before Tax | $37.51M | $79.68M | $41.17M | $47.69M |
| Income Before Tax Ratio | $0.16 | $0.25 | $0.17 | $0.19 |
| Income Tax Expense | $8.48M | $2.67M | $10.33M | $10.63M |
| Net Income | $29.03M | $77.005M | $30.84M | $37.06M |
| Net Income Ratio | $0.13 | $0.24 | $0.12 | $0.15 |
| EPS | $0.41 | $1.09 | $0.43 | $0.51 |
| Diluted EPS | $0.40 | $1.08 | $0.43 | $0.50 |
| Weighted Avg Shares Outstanding | $70.80M | $70.65M | $71.73M | $74.13M |
| Weighted Avg Shares Outstanding (Diluted) | $72.56M | $71.30M | $71.73M | $74.13M |
Financial performance has remained strong, with revenue growing from $248.38M in Q2 2024 to $232.20M in Q1 2025. Gross profit continued to perform well, with margins at 58% in the latest quarter. Operating income reached $40.09M in Q1 2025, holding a steady 17% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $68.38M. Net income dropped to $29.03M, keeping EPS at $0.41. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan